- QMRO Home
- Barts Cancer Institute
- Centre for Tumour Biology
- STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer
Browse
Administrators only